(Q37259561)

19 August 2017

1 reference

title

Valuing health States for use in cost-effectiveness analysis (English)

1 reference

cost-effectiveness analysis

19 August 2017

main subject

1 reference

John Brazier

1

1 reference

19 August 2017

publication date

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

26

1 reference

19 August 2017

issue

9

1 reference

19 August 2017

page(s)

769-779

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200826090-00007

19 August 2017

exact match

0 references

cites work

Working With Children to Develop Dimensions for a Preference-Based, Generic, Pediatric, Health-Related Quality-of-Life Measure

1 reference

12 December 2020

Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values

1 reference

12 December 2020

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

1 reference

12 December 2020

Does "process utility" exist? A case study of willingness to pay for laparoscopic cholecystectomy.

1 reference

12 December 2020

The estimation of a preference-based measure of health from the SF-36.

1 reference

12 December 2020

EuroQol: the current state of play

1 reference

12 December 2020

A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety

1 reference

12 December 2020

Theory versus practice: a review of 'willingness-to-pay' in health and health care

1 reference

12 December 2020

Empirically defined health states for depression from the SF-12.

1 reference

12 December 2020

The person-trade-off approach to valuing health care programs

1 reference

12 December 2020

Using rank data to estimate health state utility models

1 reference

12 December 2020

Reprocessing data to form QALYs

1 reference

12 December 2020

Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data

1 reference

12 December 2020

Multiattribute and single-attribute utility functions for the health utilities index mark 3 system.

1 reference

12 December 2020

A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis

1 reference

12 December 2020

Estimation of a preference-based index from a condition-specific measure: the King's Health Questionnaire.

1 reference

12 December 2020

Modeling valuations for EuroQol health states

1 reference

12 December 2020

Economics, health and health economics: HYEs (healthy-years equivalent) versus QALYs (quality-adjusted live-year)

1 reference

12 December 2020

Comparing utility scores before and after hearing-aid provision : results according to the EQ-5D, HUI3 and SF-6D.

1 reference

12 December 2020

Whose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general public

1 reference

12 December 2020

Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey.

1 reference

12 December 2020

Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index

1 reference

12 December 2020

Health state values for the HUI 2 descriptive system: results from a UK survey

1 reference

12 December 2020

Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2

1 reference

12 December 2020

A cost utility analysis of mammography screening in Australia.

1 reference

12 December 2020

The Impact of Age-Related Macular Degeneration on Health Status Utility Values

1 reference

12 December 2020

Measurement of health state utilities for economic appraisal

1 reference

12 December 2020

One thousand health-related quality-of-life estimates

1 reference

12 December 2020

Cost utility analysis: what should be measured?

1 reference

12 December 2020

Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK

1 reference

12 December 2020

Exploring uncertainty in cost-effectiveness analysis.

1 reference

12 December 2020

A new explanation for the difference between time trade-off utilities and standard gamble utilities

1 reference

12 December 2020

Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available).

1 reference

12 December 2020

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

12 December 2020

10.2165/00019053-200826090-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

1018083481

0 references

1 reference